Skip to Content

  • Search

View Additional Section Content

Chronic Migraine Treatment Trial - The study is to compare the reduction at 6 months in the number of days with severe headache, with a baseline period measured while on topiramate, in participants with chronic migraine treated with topiramate and propranolol, versus those treated with topiramate and placebo.

Principal Investigator(s)
Brad Klein, M.D.
David Weisman, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Headache
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details